Moderna, Medison partner on Moderna's COVID-19 vaccine

By The Science Advisory Board staff writers

Moderna and Medison Pharma announced that they are entering into a marketing agreement for Moderna's COVID-19 vaccine across central Europe and Israel.

The commercialization agreement will apply to about 20 countries in central and Eastern Europe.

Financial details of the agreement were not disclosed.

In other Moderna news, the company has filed for Health Canada authorization for the use of its COVID-19 vaccine in adolescents ages 12 to 18; it has also applied for conditional marketing approval of the vaccine for this age group in the European Union.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?